The quarterly report which will come out this week is likely to show the GNC sales channel showing decent growth. The peer reviewed Hashimoto's Thyroiditis publication and the new plans for the board and management of the company are both very positive. Consequently, the shorts are trying to blunt a big run. So far they have been successful. Perhaps they will succeed for the next month. But do not mistake the stock's action for disappointment with either recent news item. This is manipulation 101.
Once again, your sickness has consumed you to the point that you cannot see straight. lovleybruins, bearpoacher, francogaribaldi, starwinsthistime - all the same person. The same messed up, morally bankrupt, hate-filled idiot.